Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients
Study the Patterns of Sleep Disturbance and Quality of Life During Corona Virus Disease 19 (COVID 19) Pandemic in Upper Egypt
To study the impact of COVID 19 infection on sleep habit as regards quality of sleep, emergence of insomnia.
To assess quality of life in patients after COVID 19 infection.
調査の概要
状態
詳細な説明
The year 2020 will be remembered for a cataclysmic event- the coronavirus disease 19 ( COVID 19) pandemic, caused by severe acute respiratory syndrome coronavirus 2.
COVID 19 is a serious disease that can significantly affect the daily lives of recovered patients and their families in terms of mental health problems such as post- traumatic stress, depression, anxiety, and insomnia, as well as the negative impact COVID 19 has on patients quality of life. Since the patients are not immune to future infection, it may lead to a more negative impact on patient's quality of life. Health related quality of life is an important measure that is used for assessing the impact of diseases, disorders, or disabilities on the physical, mental, and social domains of patients health. The assessment of health related quality of life (HRQol) helps healthcare providers identify the factors affecting quality of life (QoL) and recognize the aspects of COVID 19 management that needs to be enhanced for improving the QoL of patients. COVID 19 infection causes systemic inflammation leading to a surge on inflammatory mediators in the body that are known to influence sleep and vice versa.
Systemic infection related increase in the inflammatory mediators are known to increase the amount of non rapid eye movement (NREM) sleep and duration of sleep, perhaps in an attempt to save energy and counter the infection. However, different infections have varying effects on sleep. That could be one reason that COVID 19 infection has led to insomnia and worsening of sleep quality rather than increment in sleep. Not only the sleep quality has been affected during the COVID 19 pandemic, but pandemic could have led to emergence of sleep disorders as well.
It has been persuasively argued as to why elderly persons are more susceptible to contract severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection. Several factors have been discussed that worsens sleep among the elderly, including aging of the circadian network.
Considering high prevalence of these disorders, optimal management of these disorders is important during pandemic not only to reduce the risk of contracting SARS-COV-2 infection, but also to reduce adverse health consequences related to same.
This is an important area for research as the relationship appears bidirectional, improvement in sleep may be used to reduce impact of COVID 19 and vice versa.
研究の種類
入学 (予想される)
連絡先と場所
研究連絡先
- 名前:Manal Mahmoud
- 電話番号:01006502750
- メール:mahmoud82manal@gmail.com
研究連絡先のバックアップ
- 名前:Lamia Shaban
- 電話番号:01002681478
- メール:lamiashaban@yahoo.com
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Mild, moderate and severe COVID 19 cases will be included in our study. Either diagnosed by polymerase chain reaction (PCR), CT changes characteristic of COVID 19 infection or by symptomatology and laboratory investigations.
Either managed as an outpatient or admitted to hospital. Either admitted to ward or to ICU. Age above 18 years old. With no history of end stage organ failure. With no history of neurological, psychiatric disease or cerebrovascular insufficiency.
Exclusion Criteria:
- Age below 18 years old. End stage organ failure. Patients with neurological, psychiatric diseases and cerebrovascular insufficiency.
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
---|
Cases
Patients affected by COVID-19 infection
|
Control
Normal subjects not affected by COVID-19 infection
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Quality of life in coronavirus 19 disease ( COVID-19) patients
時間枠:One month after the infection
|
Euro quality of life (Euro QoL) questionnaire in which higher scores mean a worse outcome. Minimum value is 11111 Maximum value is 55555 |
One month after the infection
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
To assess quality of sleep in coronavirus 19 ( COVID-19) patients using Epworth sleepiness scale (ESS).
時間枠:One month after infection
|
ESS in which higher scores mean worse outcomes.
ESS minimum value is zero, while maximum value is 24
|
One month after infection
|
To assess quality of sleep in coronavirus 19 ( COVID-19) patients using Pittsburgh sleep quality index ( PSQI)
時間枠:One month after the infection.
|
PSQI in which higher scores mean worse outcomes.
PSQI minimum value is zero, while maximum value is 21
|
One month after the infection.
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Manal Mahmoud、Assiut University
出版物と役立つリンク
一般刊行物
- Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, Ho RC. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020 Mar 6;17(5):1729. doi: 10.3390/ijerph17051729.
- Wang C, Pan R, Wan X, Tan Y, Xu L, McIntyre RS, Choo FN, Tran B, Ho R, Sharma VK, Ho C. A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain Behav Immun. 2020 Jul;87:40-48. doi: 10.1016/j.bbi.2020.04.028. Epub 2020 Apr 13.
- Tan BYQ, Chew NWS, Lee GKH, Jing M, Goh Y, Yeo LLL, Zhang K, Chin HK, Ahmad A, Khan FA, Shanmugam GN, Chan BPL, Sunny S, Chandra B, Ong JJY, Paliwal PR, Wong LYH, Sagayanathan R, Chen JT, Ng AYY, Teoh HL, Ho CS, Ho RC, Sharma VK. Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore. Ann Intern Med. 2020 Aug 18;173(4):317-320. doi: 10.7326/M20-1083. Epub 2020 Apr 6. No abstract available.
- Hao F, Tan W, Jiang L, Zhang L, Zhao X, Zou Y, Hu Y, Luo X, Jiang X, McIntyre RS, Tran B, Sun J, Zhang Z, Ho R, Ho C, Tam W. Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry. Brain Behav Immun. 2020 Jul;87:100-106. doi: 10.1016/j.bbi.2020.04.069. Epub 2020 Apr 27.
- Nguyen HC, Nguyen MH, Do BN, Tran CQ, Nguyen TTP, Pham KM, Pham LV, Tran KV, Duong TT, Tran TV, Duong TH, Nguyen TT, Nguyen QH, Hoang TM, Nguyen KT, Pham TTM, Yang SH, Chao JC, Duong TV. People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health Literacy. J Clin Med. 2020 Mar 31;9(4):965. doi: 10.3390/jcm9040965.
- Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A. Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients. Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):89-96. doi: 10.1080/14737167.2018.1517046. Epub 2018 Sep 3.
- Ibarra-Coronado EG, Pantaleon-Martinez AM, Velazquez-Moctezuma J, Prospero-Garcia O, Mendez-Diaz M, Perez-Tapia M, Pavon L, Morales-Montor J. The Bidirectional Relationship between Sleep and Immunity against Infections. J Immunol Res. 2015;2015:678164. doi: 10.1155/2015/678164. Epub 2015 Aug 31.
- Cardinali DP, Brown GM, Reiter RJ, Pandi-Perumal SR. Elderly as a High-risk Group during COVID-19 Pandemic: Effect of Circadian Misalignment, Sleep Dysregulation and Melatonin Administration. Sleep Vigil. 2020;4(2):81-87. doi: 10.1007/s41782-020-00111-7. Epub 2020 Sep 26.
- Shrivastava D. Unprecedented Events do not Always Call for Unprecedented Actions. Sleep Vigil. 2020;4(1):1-2. doi: 10.1007/s41782-020-00088-3. Epub 2020 May 25. No abstract available.
- Sullivan CE. Snoring and obstructive sleep apnoea as risk factors in SARS-Cov-2: can nasal CPAP during sleep reduce pneumonia risk? Sleep Biol Rhythms. 2021;19(1):109-110. doi: 10.1007/s41105-020-00295-5. Epub 2020 Nov 7. No abstract available.
研究記録日
主要日程の研究
研究開始 (予想される)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
追加の関連 MeSH 用語
その他の研究ID番号
- Qol in Covid
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
COVID-19(新型コロナウイルス感染症)の臨床試験
-
Indonesia University募集COVID-19後症候群 | 長い COVID | COVID-19 後の状態 | COVID後症候群 | 長い COVID-19インドネシア
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, Indonesia募集COVID-19 パンデミック | COVID-19 ワクチン | COVID-19 ウイルス病インドネシア
-
Yang I. Pachankis積極的、募集していないCOVID-19 呼吸器感染症 | COVID-19 ストレス症候群 | COVID-19 ワクチンの副作用 | COVID-19 関連の血栓塞栓症 | COVID-19 集中治療後症候群 | COVID-19 関連の脳卒中中国
-
Massachusetts General Hospital募集
-
First Affiliated Hospital Xi'an Jiaotong UniversityShangluo Central Hospital; Ankang Central Hospital; Hanzhong Central Hospital; Yulin No.2 Hospital; Nuclear 215 Hospital of Shaanxi Province と他の協力者募集COVID-19(新型コロナウイルス感染症) | COVID-19後症候群 | ポスト急性COVID-19 | 急性 COVID-19中国
-
University of Roma La SapienzaQueen Mary University of London; Università degli studi di Roma Foro Italico; Bios Prevention Srl完了COVID-19 の急性後遺症 | COVID-19 後の状態 | 長期COVID | 慢性新型コロナウイルス感染症(COVID-19)症候群イタリア
-
Endourage, LLC募集長い COVID | ロング Covid19 | ポスト急性COVID-19 | 長距離COVID | 長距離COVID-19 | ポスト急性COVID-19症候群アメリカ
-
University Hospital, Ioannina1st Division of Internal Medicine, University Hospital of Ioannina募集COVID-19 肺炎 | COVID-19 呼吸器感染症 | COVID-19 パンデミック | COVID-19 急性呼吸窮迫症候群 | COVID-19 関連肺炎 | COVID 19 関連の凝固障害 | COVID-19 (コロナウイルス病 2019) | COVID-19 関連の血栓塞栓症ギリシャ
-
Erasmus Medical CenterDa Vinci Clinic; HGC Rijswijkまだ募集していませんCOVID-19後症候群 | 長い COVID | ロング Covid19 | COVID-19 後の状態 | COVID後症候群 | COVID-19 後の状態、詳細不明 | 新型コロナウイルス感染症後の状況オランダ
-
Jonathann Kuo, MD積極的、募集していないSARS-CoV2感染 | COVID-19後症候群 | 自律神経失調症 | ポスト急性 COVID-19 症候群 | 長い COVID | ロング Covid19 | COVID-19 再発 | ポスト急性COVID-19 | COVID-19急性感染後 | COVID-19 の急性後遺症 | 自律神経失調症様障害 | 自律神経失調症 起立性低血圧症候群 | COVID-19 後の状態 | COVID後症候群 | COVID-19 後の状態、詳細不明アメリカ